PAK4 functions in tumor necrosis factor (TNF) alpha-induced survival pathways by facilitating TRADD binding to the

Xiaofan Li1, Audrey Minden

  • 1Department of Biological Sciences, Columbia University, New York, New York 10027, USA.

Insights

Endogenous PAK4 is crucial for cancer cell survival and anchorage-independent growth. This study reveals PAK4

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • p21-activated kinase 4 (PAK4) is implicated in tumorigenesis due to elevated expression in cancer.
  • Previous studies primarily used overexpressed PAK4, limiting understanding of its endogenous function.
  • The role of endogenous PAK4 in cancer cell survival and specific signaling pathways remains largely unexplored.

Purpose of the Study:

  • To investigate the function of endogenous PAK4 in cancer cells using RNA interference.
  • To determine PAK4's role in cell survival, anchorage-independent growth, and tumor necrosis factor alpha (TNFα)-mediated signaling.
  • To elucidate the molecular mechanisms by which PAK4 regulates prosurvival pathways.

Main Methods:

  • RNA interference (RNAi) was employed to knock down endogenous PAK4 in HeLa cancer cells.
  • Anchorage-independent growth assays were performed to assess transformation potential.
  • Analysis of TNFα-induced signaling pathways, including TRADD binding, NFκB, and ERK activation, was conducted.

Main Results:

  • Endogenous PAK4 is essential for anchorage-independent growth in cancer cells.
  • PAK4 is required for the full activation of prosurvival pathways downstream of the TNFα receptor.
  • PAK4 facilitates TRADD binding to the TNFα receptor via kinase-dependent and -independent mechanisms, impacting NFκB and ERK activation.

Conclusions:

  • Endogenous PAK4 plays a critical role in promoting cancer cell survival and tumorigenesis.
  • PAK4 regulates prosurvival signaling through TNFα receptor-mediated pathways, a novel function for this kinase.
  • Targeting PAK4 or its downstream pathways may offer therapeutic strategies for cancer treatment.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...